These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 23748101

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM, Popa-Cherecheanu A, Popa-Cherecheanu M, Nica A, Serban D.
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [Abstract] [Full Text] [Related]

  • 28. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM.
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [Abstract] [Full Text] [Related]

  • 31. Effect of glial cell line-derived neurotrophic factor on retinal function after experimental branch retinal vein occlusion.
    Ejstrup R, Cour Ml, Kyhn MV, Heegaard S, Kiilgaard JF.
    Invest Ophthalmol Vis Sci; 2012 Sep 14; 53(10):6207-13. PubMed ID: 22915030
    [Abstract] [Full Text] [Related]

  • 32. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
    Simsek M, Citirik M, Ozates S, Ozkoyuncu D.
    Indian J Ophthalmol; 2018 Jun 14; 66(6):831-836. PubMed ID: 29785994
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
    Kim JH, Shin JP, Kim IT, Park DH.
    Invest Ophthalmol Vis Sci; 2016 Jan 01; 57(1):6-11. PubMed ID: 26746013
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU, Capone A, Singer MA, Dreyer RF, Dodwell DG, Roth DB, Shi R, Walt JG, Scott LC, Hollander DA, SHASTA Study Group.
    BMC Ophthalmol; 2015 Sep 04; 15():118. PubMed ID: 26337664
    [Abstract] [Full Text] [Related]

  • 40. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.
    Ahmadi AA, Chuo JY, Banashkevich A, Ma PE, Maberley DA.
    Can J Ophthalmol; 2009 Apr 04; 44(2):154-9. PubMed ID: 19491948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.